| 1 |
Grayson PC, Patel BA, Young NS. VEXAS syndrome. Blood. 2021; 137(26): 3591-4.
doi: 10.1182/blood.2021011455
pmid: 33971000
|
| 2 |
Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei WH, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020; 383(27): 2628-38.
|
| 3 |
Hernández-Rodríguez J, Nieścieruk J, Maślińska M. VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions. Reumatologia. 2023; 61(2): 83-5.
|
| 4 |
Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2022; 186(3): 564-74.
|
| 5 |
Kouranloo K, Dey M, Almutawa J, Myall N, Nune A. Clinical characteristics, disease trajectories and management of vacuoles, E 1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review. Rheumatol Int. 2024; 44(7): 1219-32.
|
| 6 |
Kouranloo K, Ashley A, Zhao SS, Dey M. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review. Rheumatol Int. 2023; 43(6): 1023-32.
doi: 10.1007/s00296-022-05266-2
pmid: 36617363
|
| 7 |
Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022; 28(5): 911-23.
doi: 10.1038/s41591-022-01810-6
pmid: 35585196
|
| 8 |
Rayner DG, Wang E, Su C, Patel OD, Aleluya S, Giglia A, Zet al. Risk factors for long COVID in children and adolescents: a systematic review and meta-analysis. World J Pediatr. 2024; 20(2):133-42.
doi: 10.1007/s12519-023-00765-z
pmid: 38055113
|
| 9 |
Ferrada MA, Sikora KA, Luo YM, Wells KV, Patel B, Groarke EM, et al. Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol. 2021; 73(10): 1886-95.
|
| 10 |
Huang HJ, Zhang WJ, Cai WY, Liu JQ, Wang HJ, Qin TJ, et al. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder. Exp Hematol Oncol. 2021; 10(1): 23.
|
| 11 |
Yang XX, Li ZH, Zhao DQ, Yang F, Wu D, Jiang Y, et al. A case of VEXAS syndrome. Natl Med J China. 2023; 103(1): 46-8.
|
| 12 |
Kao RL, Jacobsen AA, Billington CJ Jr, Yohe SL, Beckman AK, Vercellotti GM, et al. A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis. 2022; 93: 102636.
|
| 13 |
Rivera EG, Patnaik A, Salvemini J, Jain S, Lee K, Lozeau D, et al. SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination. Clin Immunol. 2022; 238: 109027.
|
| 14 |
Skowron F, Klepfisch L, Guillaume L, Godeneche J, Facile A, Gombert M, et al. VEXAS syndrome following COVID-19 mRNA vaccination. J Eur Acad Dermatol Venereol. 2023. Epub ahead of print.
|
| 15 |
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021; 10(12): 3592.
|
)
